Leukemia

  • New treatment approach for leukemia renders cancer genes powerless

    Microscopic view of blast crisis of chronic myelogenous leukemia. © Public Health Image Library

    Cancer researcher from Mainz develops targeted epigenetic approach for the treatment of aggressive forms of leukemia

  • On track to heal leukaemia

    From left: Dr. Carsten Riether, Dr. Christian M. Schürch and Prof. Adrian F. Ochsenbein in the laboratory  Inselspital, Bern University Hospital

    The first clinical studies for a new type of immunotherapy for leukaemia are beginning at Bern’s Inselspital, Bern University Hospital. Antibodies discovered in the laboratory should inhibit the growth of tumour cells.

    Leukaemia stem cells: they have the ability to renew themselves and are resistant to most current, existing cancer therapies (chemotherapy, radiation, targeted medications). Because the cells are responsible for the development of blood cancer, they also regulate the course of disease. The faster they multiply, the faster the illness progresses.